FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

María-Luisa Gómez-Lus

Research Profile

Procedures

Chemicals & Drugs

Living Beings

Anatomy

Neutrophils

Physiology

Co-author Network

Publications

TOP 3
F Gómez-Aguado; María-Luisa Gómez-Lus; María José Alonso; María Teresa Corcuera; César García-Rey; Carmen Ramos; José Prieto
Invasion of solid culture media: a widespread phenotypic feature of clinical bacterial isolates.
Fabio Cafini; César García-Rey; María-Luisa Gómez-Lus; Isabel Sánchez; Silvia Vázquez; Pedro Bas; José Prieto
[Discrepancy in the disk diffusion susceptibility test of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients after anaerobic preincubation and its potential clinical relevance].
F Gómez-Aguado; María-Luisa Gómez-Lus; María José Alonso; Luis Alou; María Teresa Corcuera; David Sevillano; J Prieto
Evolving architectural patterns in microbial colonies development.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of María-Luisa Gómez-Lus (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: F Gómez-Aguado; María-Luisa Gómez-Lus; María José Alonso; María Teresa Corcuera; César García-Rey; Carmen Ramos; José Prieto
Invasion of solid culture media: a widespread phenotypic feature of clinical bacterial isolates.
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2013;26(1):34-8.
2012: Fabio Cafini; César García-Rey; María-Luisa Gómez-Lus; Isabel Sánchez; Silvia Vázquez; Pedro Bas; José Prieto
[Discrepancy in the disk diffusion susceptibility test of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients after anaerobic preincubation and its potential clinical relevance].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2012;25(4):269-73.
2011: F Gómez-Aguado; María-Luisa Gómez-Lus; María José Alonso; Luis Alou; María Teresa Corcuera; David Sevillano; J Prieto
Evolving architectural patterns in microbial colonies development.
Microscopy research and technique 2011;74(10):925-30.
2007: Angel Ponferrada; Javier Caso; Luis Alou; Arturo Colón; David Sevillano; Maria Moro; ignacio lizasoain; Pedro Menchén; María-Luisa Gómez-Lus; Pedro Lorenzo; Enrique Cos; Juan C Leza; Luis Menchén
The role of PPARgamma on restoration of colonic homeostasis after experimental stress-induced inflammation and dysfunction.
Gastroenterology 2007;132(5):1791-803.
2006: Fabio Cafini; N González; M Torrico; Olatz Echeverría; David Sevillano; Luis Alou; María-José Giménez; Lorenzo Aguilar; María-Luisa Gómez-Lus
[Influence of the displacement of protein binding by ibuprofen in the activity of a third-generation cephalosporin against Streptococcus pneumoniae].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2006;19(4):332-6.
2006: José Prieto Prieto; María-Luisa Gómez-Lus
[From lysozyme to penicillin: a complex and interesting journey].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2006;19(3):291-4.
2006: María-Luisa Gómez-Lus; M T López
[The keys of an era: Wright and Fleming].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2006;19(2):187-92.
2005: María-José Giménez; María-Luisa Gómez-Lus; L Valdés; Lorenzo Aguilar
[The role of the third-generation oral cephalosporin cefditoren pivoxil in the treatment of community-acquired infection in adults].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2005;18(3):210-6.
2005: Luis Alou; Lorenzo Aguilar; David Sevillano; María-José Giménez; Olatz Echeverría; María-Luisa Gómez-Lus; José Prieto
Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model.
The Journal of antimicrobial chemotherapy 2005;55(2):209-13.
2004: Raquel Amores; Luis Alou; María-José Giménez; David Sevillano; María-Luisa Gómez-Lus; Lorenzo Aguilar; José Prieto
In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin.
International journal of antimicrobial agents 2004;24(1):79-82.
2003: Almudena Calvo; Raquel Amores; Eva Valero; F Fuentes; María-Luisa Gómez-Lus; José Prieto
Activity of oral antibiotics against respiratory tract pathogens in Spain.
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2003;16(4):436-43.
2002: José Prieto; A Calvo; María-Luisa Gómez-Lus
Antimicrobial resistance: a class effect?
The Journal of antimicrobial chemotherapy 2002;50 Suppl S2():7-12.
2002: Almudena Calvo; M J Giménez; Luis Alou; María-Luisa Gómez-Lus; Laura K Aguilar; José Prieto
Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae.
International journal of antimicrobial agents 2002;20(2):144-6.
2002: M L Anta; María-José Giménez; Luis Alou; María-Luisa Gómez-Lus; Beatriz Laguna; Lorenzo Aguilar; José Prieto
Increase of in vitro amoxycillin bactericidal activity by clavulanic acid against Neisseria meningitis using time-kill curves.
International journal of antimicrobial agents 2002;19(3):249-50.
2001: Eva Valero; David Sevillano; Almudena Calvo; R García; A Leturia; María-Luisa Gómez-Lus
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2001;14(4):358-63.
2001: David Sevillano; S Valdezate; María-Luisa Gómez-Lus
[An update on the susceptibility of Stenotrophomonas maltophilia].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2001;14(2):138-54.
2001: Luis Alou; David Sevillano; J H Bugella; F Fuentes; María-Luisa Gómez-Lus; José Prieto
Evaluation of two in vitro pharmacodynamic simulation models: microfiltration versus centrifugation-filtration.
International journal of antimicrobial agents 2001;17(5):365-70.
2000: F Fuentes; David Sevillano; IP Balcabao; María-Luisa Gómez-Lus; José Prieto
In vitro activity of clarithromycin against penicillin-susceptible and penicillin-resistant strains of Streptococcus pneumoniae in a pharmacodynamic simulation model.
Journal of chemotherapy (Florence, Italy) 2000;12(6):495-8.
2000: María-Luisa Gómez-Lus; Yolanda Alonso García; Eva Valero; Raquel Amores; F Fuentes
[Pharmacodynamic basis for the use of amoxicillin-clavulanic acid in respiratory infections due to Streptococcus pneumoniae: In vitro studies in an experimental model].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2000;13(3):306-13.
2000: María-Luisa Gómez-Lus; Lorenzo Aguilar; J Vázquez; María-José Giménez; G Ruiz; Sonsoles Berrón; F Fuentes; José Prieto
Ex vivo bactericidal activity against group C Neisseria meningitidis in seronegative subjects.
Infection 2000;28(5):305-8.
1999: José Prieto; María-José Giménez; IP Balcabao; María-Luisa Gómez-Lus; Lorenzo Aguilar
Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation.
Journal of chemotherapy (Florence, Italy) 1999;11(5):345-8.
1999: S Heredia; C Ramos; María-Luisa Gómez-Lus; José Prieto
[Effect of subinhibitory concentrations of various antimicrobials on insoluble glucan production, polystyrene adherence and bacterial surface hydrophobicity of Streptococcus sobrinus].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1999;12(3):255-63.
1999: María-Luisa Gómez-Lus; José Prieto; María-José Giménez; M García; L Anta; Lorenzo Aguilar
In vitro bactericidal activity of peak serum concentrations of co-amoxiclav, amoxicillin and vancomycin against methicillin-resistant Staphylococcus aureus.
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1999;12(2):136-9.
1998: María-Luisa Gómez-Lus; Lorenzo Aguilar; María-José Giménez; José Prieto
[Inhibitors of beta-lactamases in Streptococcus pneumoniae].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1998;11(4):382-3.
1998: Laura K Aguilar; M J Giménez; María-Luisa Gómez-Lus
[Pharmacodynamics and non-enzymatic activity of beta-lactamase inhibitors].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1998;11(4):370-1.
1998: José Prieto; Lorenzo Aguilar; María-José Giménez; D Toro; María-Luisa Gómez-Lus; Rafael Dal-Ré; IP Balcabao
In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: a controlled study with vancomycin.
Antimicrobial agents and chemotherapy 1998;42(7):1574-7.
1998: Yolanda Alonso García; M J Gómez; M C Ramos; María-Luisa Gómez-Lus; José Prieto
[The postantibiotic effect of amoxicillin/clavulanic acid on Streptococcus pneumoniae strains of different serotypes and penicillin sensitivity].
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 1998;11(2):157-60.
1998: María-Luisa Gómez-Lus; F Fuentes; J Prieto
[Post-antibiotic effect. A factor with clinical applications or simply a laboratory curiosity?].
Enfermedades infecciosas y microbiología clínica 1998;16(6):255-7.
1998: María-Luisa Gómez-Lus; María-José Giménez; José Prieto; M Martín; Jesus Frías; Lorenzo Aguilar
Effect of polymorphonuclear neutrophils on serum bactericidal activity against Streptococcus pneumoniae after amoxicillin administration.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1998;17(1):40-3.
1997: M Martín; María-Luisa Gómez-Lus; Lorenzo Aguilar; P Martínez; María-José Giménez; José Prieto
Effect of clavulanic acid and/or polymorphonuclear neutrophils on amoxicillin bactericidal activity against Streptococcus pneumoniae.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(7):512-6.
1997: María-Luisa Gómez-Lus; L Aguilar; M Martín; María-José Giménez; P Martínez; J Prieto
Intracellular and extracellular killing of a penicillin-resistant, serotype-9 strain of Streptococcus pneumoniae by polymorphonuclear leucocytes in the presence of sub-inhibitory concentrations of clavulanic acid.
The Journal of antimicrobial chemotherapy 1997;40(1):142-4.
1997: Lorenzo Aguilar; M Martín; IP Balcabao; María-Luisa Gómez-Lus; Rafael Dal-Ré; José Prieto
In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
Antimicrobial agents and chemotherapy 1997;41(6):1403-5.
1997: M Martín; Lorenzo Aguilar; IP Balcabao; María-Luisa Gómez-Lus; Rafael Dal-Ré; José Prieto
In-vitro pharmacodynamic simulation of clavulanic acid concentrations: effect on Staphylococcus aureus and Haemophilus influenzae beta-lactamase activity.
The Journal of antimicrobial chemotherapy 1997;39(2):290-2.
1997: I Herrera-Insúa; P Pérez; P Martínez; María-Luisa Gómez-Lus; José Prieto
Meropenem-induced alteration of the susceptibility of Escherichia coli and Staphylococcus aureus to the bactericidal activity of human polymorphonuclear leucocytes.
The Journal of antimicrobial chemotherapy 1997;39(2):223-8.
1997: I Herrera-Insúa; P Pérez; C Ramos; P Martínez; María-Luisa Gómez-Lus; José Prieto
Synergistic effect of azithromycin on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leukocytes.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1997;16(1):13-6.
1995: P Pérez Fernández; I Herrera; P Martínez; María-Luisa Gómez-Lus; J Prieto
Enhancement of the susceptibility of Staphylococcus aureus to phagocytosis after treatment with fosfomycin compared with other antimicrobial agents.
Chemotherapy 1995;41(1):45-9.
1994: P Pérez; I Herrera; M Martín; P Martínez; María-Luisa Gómez-Lus
Enhanced susceptibility of Escherichia coli pretreated with RP7293 to leukocyte activity: comparison with other antimicrobial agents.
Chemotherapy 1994;40(2):99-103.
1993: P Pérez; I Herrera; M Martín; María-Luisa Gómez-Lus; J Prieto
[Effect of ciprofloxacin on the phagocytosis of Escherichia coli by human polymorphonuclear leukocytes].
Enfermedades infecciosas y microbiología clínica 1993;11(8):411-4.
1990: Rafael Gómez-Lus; M J Rivera; María-Luisa Gómez-Lus; J Gil; S Gómez-Lus; J Castillo; Pilar Goñi; P Madero; M Carmen Rubio
Resistance to apramycin in two enterobacterial clinical isolates: detection of a 3-N-acetyltransferase IV.
Journal of chemotherapy (Florence, Italy) 1990;2(4):241-3.
1989: M Carmen Rubio; J Gil; J Castillo; Isabel Otal; María-Luisa Gómez-Lus; E Rubio; C Sarraseca; A Torrellas; Rafael Gómez-Lus
The susceptibility to amoxycillin/clavulanate of Enterobacteriaceae with plasmid-mediated ampicillin resistance: a twelve-year study of strains in one Spanish hospital.
The Journal of antimicrobial chemotherapy 1989;24 Suppl B():35-40.
1989: I Corrales; A Suarez; A Lima; S Ballestero; María-Luisa Gómez-Lus; J Prieto
Clindamycin and tetracycline as immunomodulating agents: an in vivo study.
Drugs under experimental and clinical research 1989;15(9):409-15.
1988: M J Rivera; Carlos Martín; María-Luisa Gómez-Lus; L Robledano; Isabel Otal; Rafael Gómez-Lus
Characterization of an hospital disseminated plasmid encoding resistance to gentamicin and other antimicrobial agents.
Microbiología (Madrid, Spain) 1988;4(1):55-9.
1987: Rafael Gómez-Lus; M Carmen Rubio; C García; María-Luisa Gómez-Lus; M C Alejandre
Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli.
Drugs under experimental and clinical research 1987;13(3):155-9.